Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EMvision Medical Devices Ltd. ( (AU:EMV) ) has shared an update.
EMvision Medical Devices Ltd announced a change in the director’s interest, with Carmel Monaghan acquiring 200,000 unlisted options at an exercise price of $3.00, set to expire on December 31, 2028. This change, approved at the company’s AGM, reflects a strategic move to align the interests of the director with the company’s growth objectives, potentially impacting stakeholder confidence and market perception positively.
The most recent analyst rating on (AU:EMV) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.
More about EMvision Medical Devices Ltd.
EMvision Medical Devices Ltd operates in the medical devices industry, focusing on developing innovative imaging technologies for healthcare applications.
Average Trading Volume: 86,792
Technical Sentiment Signal: Buy
Current Market Cap: A$173.8M
For detailed information about EMV stock, go to TipRanks’ Stock Analysis page.